COVID-19 | Diagnostics | WHO
Novel coronavirus identified as cause of a cluster of pneumonia cases in Wuhan, China
On Jan. 9, 2020, the World Health Organization announced that a novel coronavirus had been identified as the…
Biotechnology | Vaccine | WHO
New pneumococcal vaccine from Serum Institute of India achieved WHO prequalification
On Dec. 19, 2019, the WHO announced that PNEUMOSIL, a vaccine against a leading cause of deadly childhood…
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Biotechnology | Measles | Polio | Vaccine
PAHO/WHO announced measles elimination in the Americas
On Sept. 27, 2016, the Region of the Americas was the first in the world to have eliminated…
FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 years
On Jul. 12, 2016, Pfizer announced that Prevnar 13ﾮ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received FDA…
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations regarding the intervals between PCV13 and PPSV23 vaccines
On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
Biotechnology | Disease | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of PCV13 and PPSV23 vaccines in adults age 65 and older
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Biotechnology | CDC | Diagnostics | Vaccine
CDC issued recommendations for PCV and PPSV vaccination of children with immunocompromising conditions
On Jun. 28, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate…
FDA approved use of Prevnar 13 vaccine in older children and teens (6-17 years)
On Jan. 25, 2013, Pfizer announced the FDA had granted approval for the expansion of the companyﾒs pneumococcal…
Biotechnology | FDA | Influenza | Vaccine
FDA expanded use of Prevnar 13 vaccine to include people ages 50 and older
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
FDA approved licensure of Pneumococcal 13-valent conjugate vaccine
On Feb. 24, 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, a subsidiary of Pfizer])…
CDC recommended pneumococcal vaccination to help prevent secondary infections
On Nov. 16, 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended a single dose of…
Global Coalition against Child Pneumonia held first World Pneumonia Day
On Nov. 12, 2009, the Global Coalition against Child Pneumonia was established to raise awareness about the toll…
Federal Medicare rule required all long-term care facilities to offer vaccination for influenza and pneumococcal disease
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | WHO
SARS (Severe Acute Respiratory Syndrome) was first discovered in Asia
On Mar. 6, 2003, the Singapore Ministry of Health (MOH) and the World Health Organization (WHO), announced they…
ACIP recommended booster doses of pneumococcal polysaccharide vaccine
On April 4, 1997, the Immunization Practices Advisory Committee (ACIP) recommended that the vaccine be used more extensively…
Recommendations for routine 2nd doses of measles-containing vaccine were issued by both ACIP and AAP
In 1989, recommendations for routine 2nd doses of measles-containing vaccine were issued by both ACIP and the American…
Biotechnology | CRISPR | Diagnostics | Disease | NIH | Therapeutics
Dr. Marilyn Hughes Gaston published groundbreaking study that led to a national sickle cell disease screening program
In 1986, Dr. Marilyn Hughes Gaston while deputy branch chief of the Sickle Cell Disease Branch at the…
Two enhanced pneumococcal polysaccharide vaccines were licensed
On Jun. 30, 1983, the U.S. Food and Drug Administration (FDA) licensed two enhanced pneumococcal polysaccharide vaccines (Pneumovax…
The costs of pneumococcal vaccine and its administration became a covered benefit under Medicare Part B
On Jul. 1, 1981, as a result of the enactment of Public Law 96-611 passed by the U.S….
Biotechnology | CDC | Diagnostics | Disease | Rare Disease
The Centers for Disease Control and Prevention reported the first cases of AIDS
On Jun. 5, 1981, Dr. Michael Gottlieb and colleagues of University of California at Los Angeles reported a…
Biotechnology | CDC | Diagnostics | Influenza | Vaccine
CDC began collecting reports of influenza outbreaks from state and territorial epidemiologists
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) began collecting reports of influenza outbreaks from…
The CDC held its first international conference on Legionnaires’ disease
In 1978, the U.S. Centers for Disease Control and Prevention (CDC) held its first international conference on Legionnaires’…
The first pneumococcal vaccine was licensed
On Nov. 21, 1977, the U.S. Food and Drug Administration (FDA) licensed the first pneumococcal vaccine containing 14…
The CDC isolated Legionella pneumophila, which caused Legionnaires’ disease in Philadelphia
In 1977, the U.S. Centers for Disease Control and Prevention (CDC) isolated Legionella pneumophila, which caused a deadly…
Biotechnology | CDC | Diagnostics | FDA | Influenza | Life Science History | Therapeutics | Vaccine
H1N1 outbreak at Fort Dix lead to a vaccination program to prevent a pandemic
In 1976, Influenza A/Victoria-like strains had been identified in New Jersey as early as January 21. The novel…
CDC launched the 122 Cities Mortality Reporting System
In 1962, the U.S. Centers for Disease Control and Prevention (CDC) launched the 122 Cities Mortality Reporting System….
Burkholderia cepacia first described
In 1949, Walter Hagemeyer Burkholder, a pioneer in bacterial taxonomy, described the bacteria, Pseudomonas cepacia, now known as…
“Louisiana pneumonitis,” a human disease possibly related to psittacosis, was discovered
In 1942, “Louisiana pneumonitis,” a human disease possibly related to psittacosis, was discovered and studied in great detail…
The Stanley Cup playoffs between the Montreal Canadians and the Seattle Metropolitans cancelled by Spanish flu
On Apr. 1, 1919, the Stanley Cup playoffs between the Montreal Canadians and the Seattle Metropolitans ended tied…